The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treatment For Esophageal Inflammation - EP2585075

The patent EP2585075 was granted to Meritage Pharma on Sep 22, 2021. The application was filed on Jun 24, 2011 under application number EP11799004A. The patent is currently recorded with a legal status of "Revoked".

EP2585075

MERITAGE PHARMA
Application Number
EP11799004A
Filing Date
Jun 24, 2011
Status
Revoked
Dec 9, 2022
Publication Date
Sep 22, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DR FALK PHARMAMay 4, 2022LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2009123550
INTERNATIONAL-SEARCH-REPORTUS2009181099
INTERNATIONAL-SEARCH-REPORTUS2011081411
INTERNATIONAL-SEARCH-REPORTWO2009132048
OPPOSITIONEP2585075
OPPOSITIONUS2007111978
OPPOSITIONUS2009123550
OPPOSITIONUS2009181099
OPPOSITIONWO2009132048
OPPOSITIONWO2011163614
SEARCHUS2009123550
SEARCHUS2009181099
SEARCHWO2009132048

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents